BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28727740)

  • 21. Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity.
    Villatoro AJ; Alcoholado C; Martín-Astorga MDC; Rubio N; Blanco J; Garrido CP; Becerra J
    PLoS One; 2022; 17(2):e0264001. PubMed ID: 35167620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
    Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
    J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells.
    Roelants V; Labar D; de Meester C; Havaux X; Tabilio A; Gambhir SS; Di Ianni M; Bol A; Bertrand L; Vanoverschelde JL
    J Nucl Med; 2008 Nov; 49(11):1836-44. PubMed ID: 18984872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
    Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
    Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.
    Li LQ; Shen F; Xu XY; Zhang H; Yang XF; Liu WG
    ScientificWorldJournal; 2013; 2013():951343. PubMed ID: 23533367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
    Wang ZX; Bian HB; Yang JS; De W; Ji XH
    Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
    Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.
    Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ
    Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells.
    Tang Y; Li J; Zhao S; Liu J
    J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant.
    Qiao J; Black ME; Caruso M
    Hum Gene Ther; 2000 Jul; 11(11):1569-76. PubMed ID: 10945770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.
    Sekar TV; Foygel K; Ilovich O; Paulmurugan R
    Theranostics; 2014; 4(5):460-74. PubMed ID: 24669276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
    Klatzmann D
    Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.
    Martinez-Quintanilla J; Bhere D; Heidari P; He D; Mahmood U; Shah K
    Stem Cells; 2013 Aug; 31(8):1706-14. PubMed ID: 23389839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models.
    Garcia-Rodríguez L; Abate-Daga D; Rojas A; González JR; Fillat C
    Gene Ther; 2011 Jan; 18(1):73-81. PubMed ID: 20720574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.